While it has been known that periodontal disease is linked to disease exacerbations in COPD, the association has not been investigated in patients with bronchiectasis. A clinical trial is in early stages to explore the relationship in this patient group.

The description of the trial, “Assessment of the quantity of microorganisms associated with bronchiectasis in saliva, sputum and nasal lavage after periodontal treatment: a study protocol of a randomised controlled trial,” was published in the journal BMJ Open.

Periodontal disease is an inflammatory condition of the gums caused by bacterial infection. Researchers believe that aspiration of pathogens may cause exacerbations in lung diseases such as pneumonia, asthma, and COPD.

Read more at www.bronchiectasisnewstoday.com